Bolt Biotherapeutics Inc

NASDAQ:BOLT  
15.32
-0.32 (-2.05%)
Products, Strategic Combinations

Bolt Biotherapeutics And Innovent Biologics Announce Collaboration

Published: 08/26/2021 20:27 GMT
Bolt Biotherapeutics Inc (BOLT) - Bolt Biotherapeutics Inc -.
Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody™ Isac Programs.
Bolt Biotherapeutics Inc - Innovent Will Pay Bolt an Upfront Payment and Fund Development Through Clinical Proof of Concept.
Bolt Biotherapeutics Inc - Innovent Has Rights to All Programs in Greater China.
Bolt Biotherapeutics Inc - Both Parties Have Options to Participate in Full Development and Commercialization for Various Regions.